Peter H Addy
@peterhaddyphd.bsky.social
Educator, psychotherapist, clinical supervisor.
The FDA just expanded approval for Johnson & Johnson's Spravato (esketamine) nasal spray, allowing it to be used as a standalone treatment for severe depression rather than only as an add-on to traditional antidepressants.
June 6, 2025 at 6:11 PM
The FDA just expanded approval for Johnson & Johnson's Spravato (esketamine) nasal spray, allowing it to be used as a standalone treatment for severe depression rather than only as an add-on to traditional antidepressants.
Oregon's psilocybin services just hit a remarkable milestone: 8,000 people have completed therapy sessions in the state's first full year of operation. That's 3 times more than all previous psilocybin clinical trials combined. With only 5 emergency calls, the safety profile is impressive.
June 4, 2025 at 5:10 PM
Oregon's psilocybin services just hit a remarkable milestone: 8,000 people have completed therapy sessions in the state's first full year of operation. That's 3 times more than all previous psilocybin clinical trials combined. With only 5 emergency calls, the safety profile is impressive.
Transpersonal psychology provides a crucial framework for understanding what happens in psychedelic therapy when clients report experiences beyond their ordinary sense of self. Rather than pathologizing these experiences, transpersonal approaches recognize them as potentially healing and meaningful.
June 2, 2025 at 4:09 PM
Transpersonal psychology provides a crucial framework for understanding what happens in psychedelic therapy when clients report experiences beyond their ordinary sense of self. Rather than pathologizing these experiences, transpersonal approaches recognize them as potentially healing and meaningful.